Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | SKB264 |
Trade Name | |
Synonyms | SKB 264|SKB-264|ADC SKB264|MK-2870|MK 2870|MK2870 |
Drug Descriptions |
SKB264 is an antibody-drug conjugate consisting of a monoclonal antibody that targets trophoblast cell surface protein 2 (TROP2) linked to an undisclosed cytotoxic agent, which delivers the drug to TROP2-expressing tumor cells, potentially inhibiting tumor cell proliferation (NCI Drug Dictionary). |
DrugClasses | TROP2 Antibody 7 |
CAS Registry Number | NA |
NCIT ID | C166409 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Pembrolizumab + SKB264 | Pembrolizumab SKB264 | 0 | 2 |
SKB264 | SKB264 | 0 | 3 |